Results presented on Tuesday at the American Association for Cancer Reserch include data on the combined use of tissue and ...

With its Oncobiota platform, Micronoma is pioneering the analysis of the cancer microbiome for ... possible to use plasma samples to detect cell-free-circulating DNA derived from tumors (ctDNA ...

By identifying residual disease—which Haystack achieves through accurately measuring circulating tumor DNA ... These remaining cancer cells, commonly referred to as minimal residual disease ...

Improved methods for circulating tumor cell capture and analysis can ensure reproducible biomarker and omics insights across different cancer types. Mouadh Barbirou, is a molecular biologist at the ...

The team is exploring whether biomarker testing could also identify patients who benefit more from immune checkpoint inhibitors after radiation.

A new, error-corrected method for detecting cancer from blood ... of the Englander Institute for Precision Medicine and associate professor of medicine and of cell and developmental biology ...

Detection requires precision because most RNA circulating in the bloodstream originates from blood-forming cells rather than tumors. Rare tumor-derived RNA molecules are often masked by the ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the results of a study ...

Human circulating tumor DNA “was overall consistently shorter than the fragment length of normal cell-free DNA,” the authors wrote in their paper. The findings could help improve cancer diagnosis and ...

Perlman Department of Dermatology at NYU Grossman School of Medicine ... “The discovery of cell-free, circulating tumor DNA (ctDNA) as a direct, albeit imperfect, measurement of tumor ...

It can also detect cancer risk. This technology identifies changes in the immune system. It aids in precision ... amounts of circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs ...